Veeva Systems
VEEV · NYSE
About VEEV
- Employees
- 7,928
- Headquarters
- Pleasanton, California
- Listed
- Oct 16, 2013
- Sector
- Health Care
- Industry
- Health Care Technology
- Website
- veeva.com
VEEV key statistics
- Market cap
- 50.25B
- Price-earnings ratio
- 51.85
- Dividend yield
- —
- Average volume
- 1.47M
- Volume
- 1.19M
- Open price
- $318.00
- High today
- $322.00
- Low today
- $310.38
- 52 Week high
- $319.95
- 52 Week low
- $148.05
Veeva Systems (VEEV) at a glance
As of Oct 20, 2026, Veeva Systems (VEEV) shares are priced at $318.67, giving the company a market cap of 50.25B and a price-to-earnings ratio of 51.85.
Today the stock has traded between $310.38 and $322.00. The current price is 2.7% above the day's low and 1.0% below its high.
Volume so far is 1.19M shares, in line with the average of 1.47M shares a day.
Over the past year Veeva Systems has ranged from $148.05 to $319.95, and now sits 99% of the way up that range.
Veeva Systems met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY27 it reported $2.35 per share against an estimate of $2.27.
The average analyst price target is $300.34, 5.8% below the current price, from 24 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy66.7%
- Hold29.2%
- Sell4.2%
- Low
- $181.80
- Now
- $318.67
- High
- $367.50
VEEV earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 5.5% on average.
- Q3 FY25: reported $1.75 per share against an estimate of $1.61
- Q4 FY25: reported $1.74 per share against an estimate of $1.61
- Q1 FY26: reported $1.97 per share against an estimate of $1.77
- Q2 FY26: reported $1.99 per share against an estimate of $1.94
- Q3 FY26: reported $2.04 per share against an estimate of $1.99
- Q4 FY26: reported $2.06 per share against an estimate of $1.97
- Q1 FY27: reported $2.24 per share against an estimate of $2.17
- Q2 FY27: reported $2.35 per share against an estimate of $2.27
VEEV news
- Press releasePRNewswire
- Press releaseBusiness Wire
IQVIA Selects Veeva Clinical Operations Applications
- Press releasePRNewswire
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality
- Press releasePRNewswire
Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development
- Press releaseGlobe Newswire
Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological Context
- Press releasePRNewswire
Veeva DQS Cleans Data for More Than 1 Million Subjects Across Over 1,000 Studies
- Ravikash Bakolia
Jim Cramer Says Investors Who Bet AI Would Destroy Software Stocks ‘Blew Up’ — Salesforce, Veeva and Palantir Led Q3 Comeback: Stocks to Watch Ahead
- Press releasePRNewswire
Servier Adopts Veeva OpenData Globally to Scale AI
Similar companies
Companies in the same industry as Veeva Systems
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- FRTTFort Technology$0.7121+32.63%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.